兴奋剂风暴:州卫生部门精神兴奋剂年龄调整死亡率与密歇根毒物中心基于精神兴奋剂的病例暴露随时间相关
该研究比较了2012至2018年密歇根毒物中心(MiPC)报告的苯丙胺和甲基苯丙胺暴露病例与密歇根州卫生与公众服务部(MDHHS)记录的因精神兴奋剂(包括甲基苯丙胺、MDMA、右苯丙胺、左苯丙胺和哌甲酯)导致的年龄调整死亡率。结果显示,MDHHS报告的精神兴奋剂死亡从17例增至165例,年龄调整死亡率从0.2/10万升至1.8/10万。MiPC苯丙胺暴露率与死亡率的线性回归斜率为1.93(SE 0.5,p=0.035,调整R²=0.55);甲基苯丙胺暴露率与死亡率的斜率为0.78(SE 0.27,p=0.012,调整R²=0.70),呈强相关。结论认为毒物中心与州卫生部门加强合作有助于检测和缓解这一公共卫生威胁。
要点
- 2012至2018年密歇根州精神兴奋剂相关死亡从17例增至165例,年龄调整死亡率从0.2/10万升至1.8/10万。
- MiPC甲基苯丙胺暴露率与州年龄调整精神兴奋剂死亡率强相关(斜率0.78,SE 0.27,p=0.012,调整R²=0.70)。
- MiPC苯丙胺暴露率与州年龄调整精神兴奋剂死亡率相关(斜率1.93,SE 0.5,p=0.035,调整R²=0.55)。
- 精神兴奋剂包括甲基苯丙胺、MDMA、右苯丙胺、左苯丙胺和哌甲酯。
- 毒物中心与州卫生部门合作可加强检测和缓解措施,并指导资源分配。
适用人群与场景
- 密歇根州2012至2018年因精神兴奋剂(甲基苯丙胺、MDMA、右苯丙胺、左苯丙胺、哌甲酯)暴露报告至MiPC的病例及MDHHS死亡证明中归因于精神兴奋剂过量的居民。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为生态学相关性分析,比较MiPC的ToxSentry®数据库2012-2018年苯丙胺和甲基苯丙胺暴露与MDHHS死亡证明数据。
- MDHHS报告的精神兴奋剂死亡从2012年17例增至2018年165例,年龄调整死亡率从0.2/10万升至1.8/10万。
- MiPC苯丙胺暴露率与州年龄调整精神兴奋剂死亡率线性回归:斜率1.93,SE 0.5,p=0.035,调整R²=0.55。
- MiPC甲基苯丙胺暴露率与州年龄调整精神兴奋剂死亡率线性回归:斜率0.78,SE 0.27,p=0.012,调整R²=0.70。
证据类型、等级与局限
- 证据类型为生态学研究(时间序列相关性分析),非个体水平数据,无法推断因果;局限包括仅单州数据、暴露报告可能受报告偏倚影响、未调整混杂因素。
对床旁实践的改变
- 提示急诊和ICU医生应关注精神兴奋剂(尤其是甲基苯丙胺)使用增加趋势,毒物中心暴露数据可作为区域监测工具辅助资源分配。
- 不改变具体床旁诊疗方案,但支持加强与毒物中心合作以早期发现和缓解精神兴奋剂相关公共卫生威胁。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Deaths attributable to psychostimulants with abuse potential have increased in the United States (US) in recent years. Methamphetamine use, in particular, has risen sharply. We evaluated the correlation between amphetamine- and methamphetamine-related case exposures reported to the Michigan Poison Center (MiPC) coinciding with psychostimulant age-adjusted mortality rates from the Michigan Department of Health and Human Services (MDHHS).
METHODS: We compared amphetamine and methamphetamine exposures reported to the MiPC from 2012 to 2018, queried from ToxSentry® database, to MDHHS reports on resident death certificates with attributed death due to "overdose, regardless of intent" and related cause of death attributed to psychostimulants with abuse potential. Linear regression assessed goodness-of-fit. Slope with standard error and adjusted R2 were reported. Psychostimulants included methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA), dextroamphetamine, levoamphetamine, and methylphenidate.
RESULTS: Psychostimulant deaths reported by MDHHS increased from 17 to 165 between 2012 and 2018. The average age-adjusted rate of psychostimulant-involved overdose deaths per 100,000 state residents rose from 0.2 to 1.8. Linear regression of MiPC amphetamine exposure rates with state health department-reported age-adjusted psychostimulant mortality rates yielded a slope of 1.93, SE 0.5, p value 0.035, and adjusted R2 0.55. Linear regression of MiPC methamphetamine exposure rates with state health department-reported age-adjusted psychostimulant mortality rates yielded a slope of 0.78, SE 0.27, p value 0.012, and adjusted R2 0.70 suggesting a strong correlation.
CONCLUSION: Psychostimulant use and associated deaths in the US are increasing, representing an evolving public health threat. Michigan demonstrates consistency with national trends and data from the MiPC correlates strongly with state-reported age-adjusted psychostimulant mortality rates. Strengthening collaboration between poison centers and state health departments is critical for detection and mitigation efforts and can thereby inform resource allocation.
参考来源
- Vohra V, King A, Daviskiba S, et al. Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over time. Clin Toxicol (Phila). 2020. PMID: 33295798. doi:10.1080/15563650.2020.1853143
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。